Nature Microbiology, Published online: 16 March 2026; doi:10.1038/s41564-026-02285-8
Longitudinal metatranscriptomics in a prospective cohort of 1,164 adults hospitalized for COVID-19 reveals that azithromycin offered no apparent anti-inflammatory benefit but enriched the respiratory microbiome with potential pathogens and antimicrobial resistance genes.
Read more about this post…
Credits: Source
Disclaimer




Serving